Cargando…
EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA
BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has a broad spectrum of clinical manifestations, the most common serious clinical manifestation of the coronavirus infection being pneumonia. Unfortunately, the optimal treatment approach is still uncertain. However, many studies have been co...
Autores principales: | Delen, Leman Acun, Gok, Abdullah, Kasapoglu, Umut Sabri, Cagasar, Ozlem, Gok, Zarife, Berber, Nurcan, Derya, Serdar, Tetik, Bora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364115/ https://www.ncbi.nlm.nih.gov/pubmed/37492367 http://dx.doi.org/10.20471/acc.2022.61.03.05 |
Ejemplares similares
-
Comparison of nutritional risk status assessment tools in predicting 30-day survival in critically ill COVID-19 pneumonia patients
por: Kasapoglu, Umut Sabri, et al.
Publicado: (2022) -
Peripheral Blood Smear Findings of COVID-19 Patients Provide İnformation about the Severity of the Disease and the Duration of Hospital Stay
por: Berber, Ilhami, et al.
Publicado: (2021) -
Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey
por: Delen, Leman Acun, et al.
Publicado: (2022) -
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021) -
Use of Favipiravir in Lactating Mother With COVID-19
por: Karabayır, Nalan, et al.
Publicado: (2021)